4[3]Ocon J, Mora J. Twenty- four- hour blood pressure monitoring and effects of indapamide[J ]. Am J Cardiol, 1990,65: 58H
5[4]Campbell DB, Brackman F. Cardiovascular protective properties of indapamide[ J ]. Am J Cardiol, 1990,65:11H
6[1]Chobanian AV,Bakris GL,Black HR,et al.National Heart,Lung,and Blood Institute Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure:National High Blood Pressure Education Program Coordinating Committee.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure:the JNC 7 report.JAMA,2003,289:2560-2572.
7[2]Cifkova R,Erdine S,Fagard R,et al.Practice guidelines for primary care physicians:2003 ESH/ESC hypertension guidelinest.J Hypertension,2003,21:1779-1786.
8[3]Nakashima Y,Fouad FM,Tarazi RC.Regression of left ventricular hypertrophy from systemic hypertension by enalapril.Am J Cardiol,1984,53:1044.
9[4]Sven Jorn Guul,Ingrid OS,Antti JJ.The efficacy and tolerability of enalapril in a formulation with a very low done of hydrochlorothiazide in pyper tensive patients resistant to enalapril monotherapy.AJH,1995,8:727-731.
10[5]The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension.Clin Ther,1993,15:364-373.
